Physician profile
Tamara D Spriggs
NPI 1265637953
$224.65
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.58 · 2020: $49.71 · 2021: $94.86 · 2022: $17.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $87.11 | 2020-2021 | |
| Pfizer INC. | $25.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.01 | 2019 | |
| Welch Allyn | $18.80 | 2021 | |
| Baxter Healthcare | $17.50 | 2022 | |
| Glaxosmithkline, LLC. | $17.42 | 2019 | |
| Mylan Specialty L.P. | $13.43 | 2019 | |
| Genentech USA, INC. | $12.84 | 2020 | |
| Merck Sharp & Dohme LLC | $12.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Spriggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.